scholarly journals Effect of chronic lymphocytic thyroiditis on the efficacy and safety of ultrasound‐guided radiofrequency ablation for papillary thyroid microcarcinoma

2019 ◽  
Vol 8 (12) ◽  
pp. 5450-5458 ◽  
Author(s):  
Yan Zhang ◽  
Ming‐bo Zhang ◽  
Yu‐kun Luo ◽  
Jie Li ◽  
Ying Zhang ◽  
...  
Keyword(s):  
Radiofrequency Ablation ◽  
Papillary Thyroid Microcarcinoma ◽  
Chronic Lymphocytic Thyroiditis ◽  
Efficacy And Safety ◽  
Papillary Thyroid ◽  
Ultrasound Guided ◽  
Lymphocytic Thyroiditis ◽  
Thyroid Microcarcinoma

scholarly journals Evaluation of Ultrasound-Guided Radiofrequency Ablation as a Treatment Option for Papillary Thyroid Microcarcinoma in the Isthmus: A Retrospective Study

2021 ◽  
Vol 11 ◽  
Author(s):  
Qing Song ◽  
Hanjing Gao ◽  
Xiaoqi Tian ◽  
Ling Ren ◽  
Yu Lan ◽  
...  
Keyword(s):  
Lymph Node ◽  
Retrospective Study ◽  
Radiofrequency Ablation ◽  
Lymph Node Metastasis ◽  
Papillary Thyroid Microcarcinoma ◽  
Papillary Thyroid ◽  
Ultrasound Guided ◽  
Node Metastasis ◽  
Thyroid Microcarcinoma

BackgroundAbout 3–9.2% of papillary thyroid carcinomas (PTC) are found in the isthmus, which has unique anatomic properties, making treatment more challenging. The aim of this study was to evaluate the treatment and undesirable effects of ultrasound-guided radiofrequency ablation (RFA) for PTC in the isthmus.MethodsThis retrospective case series study assessed 112 patients with single papillary thyroid microcarcinoma in the isthmus, pathologically diagnosed before RFA at the General Hospital of Chinese PLA in 2014–2018. Follow-up was performed by contrast-enhanced ultrasound (CEUS) and ultrasound examinations at 1, 3, and 6 months and every 6 months thereafter. The complete ablation (CAR), disappearance (DR), and volume reduction (VRR) rates of nodules, the incidence of complications, and the rate of lymph-node metastasis were recorded.ResultsThe CAR of the tumors was 100%. During follow-up, the volume of coagulation necrosis gradually decreased. DRs at 1, 3, 6, 12, and 18 months after RFA were 0.8% (1/112), 10.7% (12/112), 51.7% (58/112), 91.0% (102/112), and 100% (112/112), respectively. The VRR evaluated by ultrasound and CEUS gradually increased. One recurrent case (0.8%) was found at 7 months after RFA. No complications, lymph node metastasis confirmed by ultrasound, and abnormal thyroid function were observed.ConclusionsThis retrospective study shows that RFA is beneficial for the treatment of PTMC in the isthmus.

Ultrasound-Guided Radiofrequency Ablation Versus Surgery for Low-Risk Papillary Thyroid Microcarcinoma: Results of Over 5 Years' Follow-Up

Thyroid ◽  
2020 ◽  
Vol 30 (3) ◽  
pp. 408-417 ◽  
Author(s):  
Mingbo Zhang ◽  
Ralph P. Tufano ◽  
Jonathon O. Russell ◽  
Ying Zhang ◽  
Yan Zhang ◽  
...  
Keyword(s):  
Radiofrequency Ablation ◽  
Low Risk ◽  
Papillary Thyroid Microcarcinoma ◽  
Papillary Thyroid ◽  
Ultrasound Guided ◽  
Thyroid Microcarcinoma
Sign in / Sign up

Export Citation Format

Share Document